EMD Millipore Inks Biomanufacturing Deal with Samsung BioLogics

EMD Millipore and Samsung BioLogics signed a Memorandum of Understanding (MOU) for a strategic alliance to encompass a long-term supply agreement.

MilliporeSigma CEO Eyes New Technologies, Simpler Process for CAR-T Manufacturing

Udit Batra, Ph.D., told GEN, his company is working to shorten the supply chain and unclog other bottlenecks to CAR-T development besides vector supply.
Alliance will enable technology improvements and better efficiencies.

DNA2.0 and Blue Sky Biotech Forge Pact to Provide Services from Gene Synthesis to...

Companies believe that the alliance will enable technology improvements and better efficiencies.

ABL Awarded up to $102M in NIH Contract

The NIH National Institute of Allergy and Infectious Diseases awarded Advanced BioScience Laboratories a contract to provide preclinical development and cGMP manufacturing support for multiple vaccine and biologic products.

Amatsigroup Acquires Q-Biologicals

Buyer says deal enhances its ability to develop biological molecules by consolidating facilities and offerings

Scientists Generate Pneumococcal Serotype 3 Vaccine Using Synthetic Toxin Gene

Vaccine is reportedly the first in which gene customization has been used successfully to control virulence in bacteria.

In $1B Deal, Merck Sells API Business, 11-Drug Portfolio

The buyer, Dutch generics giant Aspen Group, looks to broaden offerings, global operations

Gene Synthesis Upgrades Protein Design, Massively

To advance the understanding for protein stability, thousands of computationally designed miniproteins have been generated via synthetic DNA technology, then subjected to high-throughput screening

Gore PharmBIO Opens Production Plant to Double Capacity

Enhanced cleanroom is key feature. Gore PharmBIO Products opened a new manufacturing facility, which doubles its capacity. Located in Elkton, MD, the site will house a cleanroom that is designed to be more efficient and...

Scientists Find Flagellin-Expressing Cells Immunize Mice Against Cancer

Engineered tumor cells trigger T-cell responses that protect against subsequent tumor cell challenge.

Recently Featured

Scroll Up